8.2 Metastatic CNS Disease & Epidural Spinal Cord Compression

Metastatic disease to the central nervous system represents a significant complication of systemic cancer, profoundly impacting patient quality of life and survival. The incidence of CNS metastases is rising, paradoxically due to improvements in systemic therapies that prolong overall survival but fail to cross the blood-brain barrier, allowing the CNS to serve as a sanctuary site for tumor growth. Understanding the distinct clinical trajectories of brain metastases and spinal cord compression is vital for the neuroscience nurse.

Metastatic Brain Tumors

Metastatic brain tumors are the most common intracranial neoplasms in adults, outnumbering primary brain tumors by a ratio of at least 4 to 1. They occur when cancer cells detach from a primary tumor, travel through the bloodstream (hematogenous spread), and lodge in the microvasculature of the brain.

Common Primary Sources

The most frequent primary cancers that metastasize to the brain include:

1. Lung Cancer: Accounts for about 50% of all brain metastases. Small cell and non-small cell lung cancers are both frequent culprits.
2. Breast Cancer: The second most common source, with HER2-positive and triple-negative subtypes having a particularly high propensity for CNS spread.
3. Melanoma: While less common overall, melanoma has the highest propensity to metastasize to the brain among all primary cancers.
4. Renal Cell Carcinoma and Gastrointestinal Cancers: Also significant contributors.

Pathophysiology and Location

Metastases typically lodge at the gray-white matter junction, where the caliber of blood vessels abruptly changes, trapping tumor emboli. The middle cerebral artery (MCA) distribution is the most common destination due to high blood flow. Brain metastases are frequently multiple and are characteristically surrounded by extensive vasogenic edema, which often causes more symptoms than the tumor mass itself.

Clinical Presentation

Symptoms of brain metastases mirror those of primary brain tumors, dictated by the lesion's location and the degree of surrounding edema. Common presentations include:

• Headaches: Often worse in the morning or exacerbated by Valsalva maneuvers, indicating elevated ICP.
• Focal Neurologic Deficits: Hemiparesis, aphasia, or visual field cuts depending on the location.
• Seizures: Frequently the presenting symptom, particularly with tumors near the cerebral cortex (e.g., melanoma metastases).
• Cognitive and Behavioral Changes: Subtle personality alterations or memory deficits.

Management involves controlling edema with corticosteroids (dexamethasone), preventing or treating seizures, and definitive therapies such as surgical resection for solitary accessible lesions, stereotactic radiosurgery (SRS), or whole-brain radiation therapy (WBRT) for multiple lesions.

Epidural Spinal Cord Compression (ESCC)

Epidural Spinal Cord Compression is a devastating complication of metastatic cancer and constitutes a true oncologic and neurological emergency. Prompt recognition and intervention are the only ways to prevent irreversible paraplegia or tetraplegia. ESCC occurs when metastatic tumor in the epidural space (usually extending from a vertebral body metastasis) compresses the dural sac, spinal cord, or cauda equina.

Primary Sources for ESCC

Cancers that commonly metastasize to the bone, specifically the spine, are the usual culprits. These include prostate, breast, and lung cancers, as well as multiple myeloma.

Clinical Presentation: The Warning Signs

The clinical progression of ESCC is predictable and must not be ignored:

1. Back Pain: The earliest and most common symptom, occurring in over 90% of patients. The pain is typically localized, progressive, unremitting, and classically worsens when the patient is supine or at night. Any patient with a history of cancer presenting with new or worsening back pain must be evaluated for ESCC until proven otherwise.
2. Motor Weakness: The second most common symptom, usually presenting as symmetrical proximal weakness in the lower extremities (difficulty climbing stairs or standing from a chair).
3. Sensory Changes: Numbness, tingling, or a distinct "sensory level" corresponding to the dermatome of the compression.
4. Autonomic Dysfunction: Bowel and bladder dysfunction (urinary retention, overflow incontinence, or bowel incontinence) are late signs. Once these develop, the prognosis for neurological recovery drops precipitously.

Diagnosis and Management

The gold standard for diagnosing ESCC is an MRI of the entire spine (cervical, thoracic, and lumbar) with and without contrast, as multiple non-contiguous lesions are common.

Immediate Nursing and Medical Interventions

• Corticosteroids: The absolute first step upon suspicion of ESCC, even before imaging is completed, is the administration of high-dose corticosteroids (typically Dexamethasone). Dexamethasone reduces spinal cord edema, relieving pressure, reducing pain, and potentially restoring some neurological function.
• Immobilization: The patient should be kept on flat bedrest with log-rolling precautions until spinal stability is assessed. A spinal orthosis may be required.
• Definitive Treatment: Depending on the patient's overall prognosis, tumor histology, and spinal stability, definitive treatment may involve emergent surgical decompression (e.g., laminectomy or corpectomy with stabilization) followed by radiation, or urgent radiation therapy alone if surgery is contraindicated.

The Neuroscience Nurse's Role in ESCC

The nurse plays a critical role in early detection by meticulously assessing for back pain and subtle neurological changes in oncology patients. Promptly reporting a new onset of weakness or urinary retention can mean the difference between a patient walking or being permanently wheelchair-bound. Careful management of bowel and bladder function, prevention of pressure injuries due to immobility, and providing deep emotional support during a frightening crisis are essential nursing responsibilities.